Metraipolis › archive › dc_4959ead34c28
Adverse event reporting of faricimab: a disproportionality analysis of FDA adverse event reporting system (FAERS) database — Europe PMC PMID:40144657
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40144657
- DOI
- 10.3389/fphar.2025.1521358
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T21:54:31.820Z
- SHA-256 of the archived text
893d57a2acd1ea204917a58632e5b18a1131fec9eb14fa5c655ad063bf46f7dc- Stable URL of this page
https://metraipolis.com/documento/dc_4959ead34c28
How to cite
Adverse event reporting of faricimab: a disproportionality analysis of FDA adverse event reporting system (FAERS) database — Europe PMC PMID:40144657 — Europe PMC (en), https://europepmc.org/article/MED/40144657 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4959ead34c28 (Metraipolis archive dc_4959ead34c28, sha256 893d57a2acd1ea204917a58632e5b18a1131fec9eb14fa5c655ad063bf46f7dc)
BibTeX
@misc{dc4959ead34c28,
title = {Adverse event reporting of faricimab: a disproportionality analysis of FDA adverse event reporting system (FAERS) database — Europe PMC PMID:40144657},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40144657},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4959ead34c28; sha256 893d57a2acd1ea204917a58632e5b18a1131fec9eb14fa5c655ad063bf46f7dc},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40144657. Agents can read the archived copy with the MCP tool read_document.